Delivery Order 36C25625D0125-36C25626N0795
Award Date 9/30/26
Potential Completion Date 9/30/30
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bedford, MA 01730, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 22 issued a delivery order to Werfen USA LLC on September 13, 2022, with a ceiling value of $100,934.45 for in vitro diagnostic (IVD) products on a firm fixed-price basis. The order is set to complete by September 12, 2023. Place of performance is Bedford, MA. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory instrumentation, supplies coagulation analyzers, blood gas analyzers, hematology...
- This federal contract award to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic (IVD) equipment, reagents, and services, is for the provision of BLOOD CONTROL REAGENTS. The $29,231.85 fixed-price delivery order contract was awarded on September 30, 2025, with an ultimate completion date of September 29, 2026. The funding agency is the Veterans Integrated Service Network 16 (VISN 16), a civilian agency under the Department of Veterans Affairs (VA). This...
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, received a $62,213.36 firm fixed-price delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 10 for reagent blood analysis services. This delivery order, awarded on October 1, 2021, with an ultimate completion date of September 30, 2026, represents a call against the company's existing GSA Schedule contract for In Vitro Diagnostics, Reagents, and Test...
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory reagents, received a $59,380.08 firm fixed-price delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 5 on October 1, 2022. The contract, which was completed by September 30, 2023, calls for the supply of blood reagents and products to support diagnostic testing operations at the performance location in Peachtree Corners, Georgia. This...
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of clinical laboratory diagnostic equipment and reagents, has been awarded a delivery order valued at $79,671.49 for the lease and provision of a Werfen Echo Blood Bank Analyzer and associated reagents under the In Vitro Diagnostics, Reagents, and Test schedule (FSS-65-VII). The delivery order, issued without set-aside designation, will be performed in Bedford, MA and is scheduled for completion by January 31, 2027. This award is...
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory instrumentation, was awarded a delivery order valued at $192,270.38 by the Veterans Integrated Service Network 19 (VISN 19) on April 1, 2023, with an ultimate completion date of March 31, 2025. The delivery order is issued under the In Vitro Diagnostics, Reagents, and Test GSA Schedule (FSS-65-VII) and calls for the supply of a blood bank analyzer—equipment used for...
- Veterans Integrated Service Network 22 issued a delivery order to Werfen USA LLC on September 13, 2025, for in vitro diagnostic products with a ceiling value of $54,968.89 and a firm fixed-price structure, with ultimate completion by September 12, 2026. Place of performance is Veterans Administration, CA 90073. The order is issued against a standing master agreement for laboratory diagnostic equipment and supplies. Werfen USA LLC is a Bedford, Massachusetts-based manufacturer of in vitro...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a delivery order to Werfen USA LLC for blood gas testing instruments, reagents, and consumables on a cost-per-test basis. The contract, which is not set-aside for small businesses, carries a ceiling value of $281,378.71 and extends through October 31, 2026. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment, will perform the work at its Massachusetts location. As a...
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory reagents, was awarded a delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 10 for blood bank reagents. The contract, executed on December 1, 2020, operates under a firm fixed-price structure with a ceiling value of $104,361.55 and an ultimate completion date of November 30, 2025. This delivery order is a direct call against the parent Invitro...
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory reagents, was awarded an Exercise OY2 delivery order valued at $19.5K for blood bank reagents under its existing blanket purchase agreement with Veterans Integrated Service Network 17. The award, issued August 1, 2024, with completion by July 31, 2025, represents a firm fixed-price call order under the In Vitro Diagnostics, Reagents, Test GSA Multiple Award Schedule. This contract does not...
- 36C25625D0125Indefinite Delivery Contract
- 36C25625D0125-36C25626N0795Delivery Order
Veterans Integrated Service Network 16 issued a delivery order to Werfen USA LLC on September 30, 2026, for blood control reagents with a ceiling value of $29,231.85 under firm fixed-price terms. The order has an ultimate completion date of September 30, 2030. Place of performance is Bedford, MA. Werfen USA LLC manufactures in vitro diagnostic equipment and clinical laboratory instrumentation, supplying coagulation analyzers, blood gas analyzers, hematology testing systems, blood bank analyzers, and associated reagents and consumables to federal healthcare agencies.
Generated 9/16/26, 9:49 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.2k | 9/15/26 |